STAT+: House panel advances bill to extend Medicare’s telehealth flexibilities, setting up December talks
A House committee on Wednesday advanced legislation that would extend Medicare telehealth flexibilities and a…
Category: Business
STAT+: Hospital giant Ascension recorded about $1.3 billion in losses from its cyberattack
The cyberattack that forced Ascension to shut off access to its electronic health records cost…
Bernie Sanders keeps the heat on Novo’s high prices
Want to stay on top of the science and politics driving biotech today? Sign up to get…
FDA formalizes protocol for international cancer trials
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: What Medicare Advantage enrollment could look like for next year
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
The essential biotech updates of the day
Morning! Today, we talk about bioethics, catch up on some reports from ESMO, and wonder aloud…
STAT+: Exact Sciences reports initial positive results in colon cancer blood test, but pivot trial still pending
Exact Sciences, which has for years sold a stool-based colon cancer test, on Monday announced…
Can GLP-1 drugs help with type 1 diabetes?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Insurers went all-in on Medicare Advantage. Now, some are scaling back
For years, health insurers battled to gain market share in the lucrative privatized Medicare program….
Moderna cuts spending, and Sarepta’s ‘curse’ on Califf
Good morning. If you’re following the European Society for Medical Oncology meeting that starts tomorrow,…
STAT+: Apple will offer millions of AirPod users a hearing aid. Can it convince them to use it?
After years of dabbling in hearing health, Apple earlier this week went all-in, announcing that…
Eli Lilly releases new data on weekly insulin
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Elevance buys IU Health’s insurance company
Elevance Health, the parent of more than a dozen state Blue Cross Blue Shield plans,…
Key lawmakers are wary of giving FDA more cash to crack down on e-cigs
WASHINGTON – Powerful House lawmakers from both parties are skeptical of the Food and Drug…
Five biotech news stories you need to read today
Morning! Today, we’ll keep riding the bispecific wave, and tell you what Verily and FDA…
STAT+: How powerful hospitals helped take R1 RCM private
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
Terns’ GLP-1 pill leads to weight loss in early study
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Highmark reboots coverage of digital treatments, raising hope among DTx companies
Highmark Health, a large regional health insurer that also owns a chain of hospitals, is…
STAT+: With a win in lung cancer, biotech’s wealthiest outsider surfs to new heights
On Sunday, a small biotech company called Summit Therapeutics won a remarkable victory, saying its…
STAT+: Ascension, other hospitals played active roles to take medical billing company R1 RCM private
Private equity firms are leading the buyout of R1 RCM, a major provider of billing…
Lilly has more positive data on its weekly insulin
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Humana cutting Medicare Advantage plans that cover 10% of members
Roughly 10% of people enrolled in Humana’s private Medicare plans will have to find new…
BioMarin’s big day today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: The Snoo can’t help the people who need it most
When you have a baby, sleep becomes the holy grail. You become convinced that getting…
STAT+: HCA and UnitedHealth resolve contract disputes in four states hours before deadline
HCA Healthcare and UnitedHealthcare reached agreements just hours before their contracts were scheduled to expire…
Genentech is shedding even more employees
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Hims takes a blow from Lilly’s vial news
Good morning. As a treat for Labor Day weekend, we’re running a deal for STAT+…
STAT+: UnitedHealth pledged a hands-off approach after buying a Connecticut medical group. Then it upended how doctors practice
MIDDLETOWN, Conn. — UnitedHealth Group told the Connecticut primary care doctors everything they wanted to…
STAT+: Centene eliminates brokers’ commissions for Medicare drug plans
Health insurer Centene will not pay any commissions to brokers and agents who help people…
Pfizer and Lilly want to sell you drugs directly
Want to stay on top of the science and politics driving biotech today? Sign up to get…
A Galapagos investor signals impatience with its turnaround efforts
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Continuous glucose monitoring for the masses is here. Are we ready for it?
NEW YORK — Glucose tracking is the future, Dexcom executives gushed at a glitzy launch…
STAT+: Federal judge blocks noncompete ban, and FTC considers appeal
A federal judge in Texas appointed by former President Donald Trump has officially spiked the…
STAT+: Peter Orszag wants the FTC and DOJ to stop challenging health care mergers
Peter Orszag was instrumental in crafting the Affordable Care Act. Now, he wants federal antitrust…
Is pharma still fearful of the Inflation Reduction Act?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
We have mpox vaccines now. But how will they be distributed?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Syros shares battered after it stops leukemia trial
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Otsuka starts selling depression digital therapeutic, expects to lose money on it
Otsuka Pharmaceutical has started selling Rejoyn, its Food and Drug Administration cleared prescription app that…
Atai advances oral psychedelic in depression
Want to stay on top of the science and politics driving biotech today? Sign up to get…
A tough week for MDMA-assisted psychotherapy
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What’s in a drink? U.S. regulators consider new alcohol label, but health advocates want even more
If you twirl a bottle of alcohol and squint, you might see a text box…
Why did Novo pull heart failure paperwork for Wegovy?
Hey, humans. Today, we talk about the decades-long pursuit to get MDMA approved as a…
STAT+: A strong start for Madrigal’s MASH drug launch
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
Sarepta CEO: We’re ‘pretty brilliant’
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Watch: How drug patents pave the way to profit
This is Part 3 of “Behind the Counter,” an in-depth video series demystifying the complex…
STAT+: Orlando Health, a $6 billion Florida powerhouse, is expanding into Alabama
As for-profit Tenet Healthcare slims its hospital portfolio, it found an unlikely buyer for its…
A new drug for glioma means a windfall for Agios
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: How UnitedHealth turned a questionable artery-screening program into a gold mine
The nation’s largest health care company pressed thousands of its clinicians to use a thinly…
STAT+: Tim Walz stood up to corporate health care. Mayo Clinic was a powerful exception.
MINNEAPOLIS — Even for the most progressive of politicians, money talks. And elite nonprofit hospitals…
The exclusive biotech stories you need to read
Want to stay on top of the science and politics driving biotech today? Sign up to get…